TrialFuture oncology (London, England)2025

Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial.

Myung-Ju Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.